−£1.76m
vs Oct 2024ActiveSC454814Private limited companyEdinburgh
NEUROCENTRX PHARMA LIMITED
Significant control: Scottish Enterprise (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Neurocentrx Pharma Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Neurocentrx Pharma Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
NEUROCENTRX PHARMA LIMITED is an active private limited company (company number SC454814) incorporated on 18 July 2013, registered in Edinburgh. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 December 2025, showing net assets of −£1.76m and cash of £385, with 1 employee on average. Net assets fell 135% on the prior period (−£750k).
Peer position · net assets
By net assets it sits in the bottom quarter of 62 comparable companies in Edinburgh (median £4,168, upper quartile £51k).
02
Ownership and control
- Scottish Enterprise
- owns 25–50% of shares
- holds 25–50% of voting rights
- Equity Gap Limited
- owns 25–50% of shares
- holds 25–50% of voting rights
- Mr Fraser Stuart Lusty
- has significant influence or control
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 18 July 201313 yrs ago
- Next accounts due
- 30 September 2027in 340 days
- Confirmation statement due
- 1 August 2027in 280 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£385
−99%vs Oct 2024Not reported
1
No changevs Oct 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2025 | −£1.76m | £385 | £19k | — | — | — | 1 |
| 31 October 2024 | −£750k | £34k | £48k | — | — | — | 1 |
Cash per employee£385Cash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets below zeroNet assets £-1,763,537 at 31 December 2025
- Net assets down 25% or more on the prior period-135.1% vs prior period
- Incorporated five or more years agoIncorporated 18 July 2013
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 340 days
- Confirmation statement duein 280 days
- Accounts period endNet liabilities £1.76m · small accounts
- Accounts period endNet liabilities £750k · small accounts
- Incorporated
08
Similar companies in Edinburgh
- CURAPEL (SCOTLAND) LIMITEDEdinburgh · inc. Jul 2013
- BIOASCENT DISCOVERY LIMITEDEdinburgh · inc. Feb 2013
- EDINBURGH MOLECULAR IMAGING LIMITEDEdinburgh · inc. Jan 2014
- EP PHARMACEUTICALS LTDEdinburgh · inc. Dec 2012
- ASPER RESEARCH LTDEdinburgh · inc. Oct 2012
- ILC THERAPEUTICS LTDEdinburgh · inc. Jun 2012
All companies incorporated on 18 July 2013 · in Jul 2013.
09
Reminders for NEUROCENTRX PHARMA LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.